The group's principal activities are to develop, manufacture and market invasive products to treat patients with solid cancerous or benign tumors. The group's products use radiofrequency energy to heat tissue to a high enough temperature to ablate it, or cause cell death. The group's products include radiofrequency generators and disposable needle electrode devices. Disposable devices consist of needle shaped electrodes containing curved wire arrays that are deployed into the targeted body tissue. Radio frequency generators employ an internal computer to assist the physician in safely and effectively controlling the delivery of radiofrequency during the ablation. The group's products are distributed in the United States through direct sales force and internationally through distribution partners. On 29-Jul-2004, the group acquired horizon medical products inc.
